Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MVA-MUC1-IL2 vaccine |
| Trade Name | |
| Synonyms | TG4010 |
| Drug Descriptions |
MVA-MUC1-IL2 (TG4010) is a modified vaccinia virus Ankara (MVA) strain encoding human mucin 1 (MUC1) and interleukin-2 (IL-2), for immunotherapy in cancer patients whose tumors express the MUC1 antigen (PMID: 28923084). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C2241 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| MVA-MUC1-IL2 vaccine | MVA-MUC1-IL2 vaccine | 0 | 1 |
| MVA-MUC1-IL2 vaccine + Nivolumab | MVA-MUC1-IL2 vaccine Nivolumab | 0 | 2 |